Zongyou Chen

Zongyou Chen

Auto-generated profile, based on publicly available information

Zongyou Chen

Department of General Surgery, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2015 in Biomedical Reports
Verified
Journal Article
Closed access
PDF file
BSBo Sun
Bo Sun
YFYantian Fang
Yantian Fang
ZLZhenyang Li
Zhenyang Li
ZCZongyou Chen
Zongyou Chen
JXJianbin Xiang
Jianbin Xiang
Currently, cancer metastases remain a major clinical problem that highlights the importance of recognition of the metastatic process in cancer diagnosis and treatment. A critical process associated with the metastasis process is the transformation of epithelial cells toward the motile mesenchymal state, a process called epithelial‑mesenchymal transition (EMT). Increasing evidence suggests the crucial role of the cytoskeleton in the EMT process. The cytoskeleton is composed of the actin cytoskeleton, the microtubule network and the intermediate filaments that provide structural design and mechanical strength that is necessary for the EMT. The dynamic reorganization of the actin cytoskeleton is a prerequisite for the morphology, migration and invasion of cancer cells. The microtubule network is the cytoskeleton that provides the driving force during cell migration. Intermediate filaments are significantly rearranged, typically switching from cytokeratin‑rich to vimentin‑rich networks during the EMT process, accompanied by a greatly enhanced cell motility capacity. In the present review, the recent novel insights into the different cytoskeleton underlying EMT are summarized. There are numerous advances in our understanding of the fundamental role of the cytoskeleton in cancer cell invasion and migration.

1 December 2014 in Oncology Reports
Verified
Journal Article
Closed access
PDF file
DJDanjuan Jin
Danjuan Jin
YFYantian Fang
Yantian Fang
ZLZhengyang Li
Zhengyang Li
ZCZongyou Chen
Zongyou Chen
JXJianbin Xiang
Jianbin Xiang
Colorectal cancer (CRC) is one of the most common malignancies, and the third leading cause of cancer-associated mortality worldwide. Therefore, the identification of effective targets at the early stages of cancer invasion and metastasis, and new tumor markers for early diagnosis and individualized treatment is imperative for CRC. Epithelial-mesenchymal transition (EMT) refers to the phenomenon of the transformation of epithelial cells to mesenchymal cells in specific physiological and/or pathological circumstances. Evidence suggests that EMT plays an important role in in situ infiltration and distant metastasis of many types of cancer, including CRC. Recent findings showed that microRNA expression is important in regulating the EMT process. This review aimed to summarize EMT-associated specific miRNA molecules in CRC, with particular emphasis on clinical targets for effective treatment of this lethal disease.

9 March 2013 in International Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
YFYantian Fang
Yantian Fang
CWChunhsien Wu
Chunhsien Wu
XGXiao-Dong Gu
Xiao-Dong Gu
ZLZhengyang Li
Zhengyang Li
JXJianbin Xiang
Jianbin Xiang
ZCZongyou Chen
Zongyou Chen

2 December 2014 in Molecular and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
BSBo Sun
Bo Sun
YFYantian Fang
Yantian Fang
ZLZhengyang Li
Zhengyang Li
ZCZongyou Chen
Zongyou Chen
JXJianbin Xiang
Jianbin Xiang
Nanotechnology has broad application prospects in the diagnosis and treatment of cancer. Integrating chemistry, engineering, biology and medicine, nanotechnology is a multidisciplinary research field. Nanoscale imaging technology significantly improves the precision and accuracy of tumor diagnosis. Nanocarriers are able to significantly improve the accuracy of dose and targeted drug delivery and reduce the toxic side effects. This review focuses on the emerging roles of these innovative technologies in gastrointestinal cancer diagnostics and therapeutics. Although several problems and barriers are hampering the development of nanodevices, the potential for nanotechnologies to function as multimodal nanotheranostic agents will likely pave the way for the fight against gastrointestinal cancer.